The Effect of Statins on Acute and Long-Term Outcome After Ischemic Stroke in the Elderly

被引:17
作者
Hjalmarsson, Clara [1 ]
Bokemark, Lena [1 ]
Manhem, Karin
Mehlig, Kirsten [2 ]
Andersson, Bjorn [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Internal Med, Stroke Unit, SE-40530 Gothenburg, Sweden
[2] Gothenburg Univ, Inst Med, Dept Community Med & Publ Hlth, Gothenburg, Sweden
关键词
ischemic stroke; lipids; low-density lipoprotein; statins; stroke prognosis; COA REDUCTASE INHIBITOR; RISK-FACTOR; CHOLESTEROL; METAANALYSIS; PRAVASTATIN; PREVENTION; EVENTS; PRETREATMENT; INFARCTION; MORTALITY;
D O I
10.1016/j.amjopharm.2012.09.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Although treatment with statins has produced beneficial effects when used as secondary prevention, its primary protective role is still somewhat controversial. Moreover, few studies have evaluated the effect of statins in older patients with stroke. Objective: The aim was to investigate whether treatment with statins decreases stroke severity and/or improves survival and outcome after stroke in an older population. Methods: We investigated the association between previous statin use and stroke severity (National Institutes of Health Stroke Scale [NIHSS]), as well as the effect of poststroke statin treatment on 12-month functional outcome (modified Rankin Scale [mRS] score) in 799 patients (mean age, 78 years), with acute ischemic stroke. The effect of statin treatment on survival was examined using the Cox proportional hazard model, after adjusting for relevant covariates. Results: Statins did not decrease stroke severity and did not improve 30-day survival. However, both the 12-month survival (hazard ratio = 0.33; 95% CI, 0.20-to 0.54; P < 0.001) and the 12-month functional outcome (odds ratio = 2.09; 95% CI, 1.25-3.52; P = 0.005) were significantly better in the group treated with statins. Conclusions: Significantly better survival and functional outcome were noted with poststroke statins at the end of the 12-month follow-up period. Statins seem to provide beneficial effects for the long-term functional outcome and survival in the elderly. (Am J Geriatr Pharmacother. 2012;10:313-322) (C) 2012 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:313 / 322
页数:10
相关论文
共 40 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
    Alvarez-Sabin, Jose
    Huertas, Rafael
    Quintana, Manolo
    Rubiera, Marta
    Delgado, Pilar
    Ribo, Marc
    Molina, Carlos A.
    Montaner, Joan
    [J]. STROKE, 2007, 38 (03) : 1076 - 1078
  • [3] Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice
    Amin-Hanjani, S
    Stagliano, NE
    Yamada, M
    Huang, PL
    Liao, JK
    Moskowitz, MA
    [J]. STROKE, 2001, 32 (04) : 980 - 985
  • [4] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [5] Neuroprotection by pravastatin in acute ischemic stroke in rats
    Berger, Christian
    Xia, Feng
    Maurer, Martin H.
    Schwab, Stefan
    [J]. BRAIN RESEARCH REVIEWS, 2008, 58 (01) : 48 - 56
  • [6] Statin Treatment and Functional Outcome After Ischemic Stroke Case-Control and Meta-Analysis
    Biffi, Alessandro
    Devan, William J.
    Anderson, Christopher D.
    Cortellini, Lynelle
    Furie, Karen L.
    Rosand, Jonathan
    Rost, Natalia S.
    [J]. STROKE, 2011, 42 (05) : 1314 - 1319
  • [7] Statin treatment withdrawal in ischemic stroke -: A controlled randomized study
    Blanco, M.
    Nombela, F.
    Castellanos, M.
    Rodriguez-Yanez, M.
    Garcia-Gil, M.
    Leira, R.
    Lizasoain, I.
    Serena, J.
    Vivancos, J.
    Moro, M. A.
    Davalos, A.
    Castillo, J.
    [J]. NEUROLOGY, 2007, 69 (09) : 904 - 910
  • [8] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE
    BROTT, T
    ADAMS, HP
    OLINGER, CP
    MARLER, JR
    BARSAN, WG
    BILLER, J
    SPILKER, J
    HOLLERAN, R
    EBERLE, R
    HERTZBERG, V
    RORICK, M
    MOOMAW, CJ
    WALKER, M
    [J]. STROKE, 1989, 20 (07) : 864 - 870
  • [9] Statin use and sex-specific stroke outcomes in patients with vascular disease
    Bushnell, Cheryl D.
    Griffin, Jeffrey
    Newby, L. Kristin
    Goldstein, Larry B.
    Mahaffey, Kenneth W.
    Graffagnino, Carmelo A.
    Harrington, Robert A.
    White, Harvey D.
    Simes, R. John
    Califf, Robert M.
    Topol, Eric J.
    Easton, J. Donald
    [J]. STROKE, 2006, 37 (06) : 1427 - 1431
  • [10] Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
    Chen, JL
    Zhang, ZG
    Li, Y
    Wang, Y
    Wang, L
    Jiang, H
    Zhang, CL
    Lu, M
    Katakowski, M
    Feldkamp, CS
    Chopp, M
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (06) : 743 - 751